| AhR MODULATORS |
2022-6-29 |
2023-2-09 |
|
| O-linked thiadiazolyl compounds as dna polymerase theta inhibitors |
2022-6-09 |
2022-12-15 |
|
| Combination therapy comprising a mat2a inhibitor and type i prmt inhibitor |
2022-6-01 |
2022-12-08 |
|
| Combination therapy comprising a mat2a inhibitor and a type ii prmt inhibitor |
2022-6-01 |
2022-12-08 |
|
| Combination therapy comprising a pkc inhibitor and a mek inhibitor |
2022-4-14 |
2022-10-20 |
|
| 4-substituted indole and indazole sulfonamido derivatives as parg inhibitors |
2022-3-16 |
2022-5-01 |
|
| Substituted thiadiazolyl derivatives as dna polymerase theta inhibitors |
2021-12-01 |
2022-6-09 |
|
| Pharmaceutical combination and tumor treatment |
2021-9-07 |
2022-3-17 |
|
| Pharmaceutical combination and tumor treatment |
2021-9-07 |
2022-3-17 |
|
| Acetamido-amino and acetamido-sulfur derivatives as dna polymerase theta … |
2021-7-28 |
2022-2-03 |
|
| Cyclized acetamido derivatives as dna polymerase theta inhibitors |
2021-7-28 |
2022-2-03 |
|
| 2-Oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors |
2021-7-06 |
2021-7-30 |
|
| 2-aminoquinazolinone derivatives as methionine adenosyltransferase 2a … |
2021-6-09 |
2021-12-16 |
|
| 4-arylquinazoline derivatives as methionine adenosyltransferase 2a inhibitors |
2021-6-09 |
2021-12-16 |
|
| Quinolinone derivatives as methionine adenosyltransferase 2a inhibitors |
2021-6-09 |
2021-12-16 |
|
| Heteroaryl alkylene substituted 2-oxoquinazoline derivatives as methionine … |
2021-6-09 |
2021-12-16 |
|
| Dosing regimens for a protein kinase c inhibitor |
2020-11-18 |
2021-5-27 |
|
| Thiadiazolyl derivatives as DNA Polymerase Theta inhibitors |
2020-5-29 |
2021-12-23 |
|
| Method for treating epidermal growth factor receptor-driven cancers with … |
2020-3-26 |
2020-10-01 |
|
| HETEROARYLMETYLENE DERIVATIVES AS INHIBITORS OF DNA POLYMERASE THETA |
2020-1-30 |
2021-10-05 |
|
| Heteroarylmethylene derivatives as dna polymerase theta inhibitors |
2020-1-30 |
2021-12-16 |
|
| Acetamido derivatives as DNA Polymerase Theta inhibitors |
2020-1-29 |
2021-8-19 |
|
| Acetamide Derivatives as DNA Polymerase Theta Inhibitors |
2020-1-29 |
2021-10-05 |
|
| Treatment of cancer having gnaq or gna11 genetic mutations with protein kinase … |
2020-1-07 |
2020-7-16 |
|
| Parg inhibitory compounds |
2019-10-24 |
2020-5-28 |
|
| Methods of culturing and/or expanding stem cells and/or lineage committed … |
2019-7-18 |
2020-1-23 |
|
| How to suppress proliferative cells |
2019-6-17 |
2021-10-14 |
|
| Methods of culturing and/or expanding stem cells and/or lineage committed … |
2019-6-05 |
2019-12-12 |
|
| Substituted imidazo[1,5-a]pyrazines and [1,2,4]triazolo[4,3-a]pyrazines for the … |
2019-2-05 |
2022-12-20 |
2022-12-20 |
| DIHYDROTHIENO[3,2-b]PYRIDINE COMPOUNDS |
2018-9-25 |
2022-7-21 |
|
| AMIDO COMPOUNDS AS AhR MODULATORS |
2018-7-18 |
2021-4-22 |
|
| Combinaison pharmaceutique et traitement antitumoral |
2021-9-07 |
2022-3-17 |
|
| Derivados de heteroarilmetileno como inibidores de dna polimerase teta |
2020-1-30 |
2021-10-05 |
|
| Derivados de acetamido como inibidores de dna polimerase teta |
2020-1-29 |
2021-10-05 |
|